KREMPA DAVID (Chief Business Officer) reported 1 transaction at ETON PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/12/2025ACC: 0001437749-25-037745
Officer· Chief Business Officer
Since Mar 2023
-964.00
Net shares
Net seller
$106.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
5.30K acquired · 6.26K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.26K
Price / share
$17.00
Trade value
$106.49K
% of position
1.0%
12/12/2025
638.44K→632.18K
Total
Net shares
−6.26K
Net value
-$106.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/12/2025 | F · Tax Withholding | −6.26K | $17.00 | $106.49K | 1.0% | 638.44K | 632.18K |
| Total | −6.26K | -$106.49K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
5.30K shares
Shares
+5.30K
Strike price
Held after
638.47K
Exercisable
—
12/11/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock5.30K shares | 12/11/2025 | A · Award | +5.30K | — | 638.47K |